Browsing by Ajou Author

researcher image
서, 창희(Suh, Chang Hee) Currently indexed / E-mail
[School of Medicine / Graduate School of Medicine] - [Rheumatology]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 51 to 100 of 310

This table browses all dspace content
Pub YearTitle & CitationAJOU Author(s)
2021An update on the pathogenic role of neutrophils in systemic juvenile idiopathic arthritis and adult-onset still’s disease
International journal of molecular sciences, 22(23). : 13038-13038, 2021
김지원, 김현아, 서창희, 안미현, 정주양
2021Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus
International journal of molecular sciences, 22(3). : 1374-1374, 2021
김현아, 서창희, 정주양
2021Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature
Medicine, 100(32). : e26843-e26843, 2021
김영배, 김지원, 김현아, 서창희, 정주양
2021Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus
Annals of the rheumatic diseases, 80(5). : 632-640, 2021
서창희
2021Lupus low disease activity state achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus
The Journal of rheumatology, 48(5). : 707-716, 2021
곽동욱, 김지원, 김현아, 서창희, 양정인, 정주양
2021Impact of infliximab biosimilar ct-p13 dose and infusion interval on real-world drug survival and effectiveness in patients with ankylosing spondylitis
Journal of clinical medicine, 10(19). : 4568-4568, 2021
서창희
2021The assessment of muscle mass and function in patients with long-standing rheumatoid arthritis
Journal of clinical medicine, 10(16). : 3458-3458, 2021
김지원, 김춘자, 김현아, 서창희, 정주양
2021Anti-inflammatory effects of low-dose glucocorticoids compensate for their detrimental effects on bone mineral density in patients with rheumatoid arthritis
Journal of clinical medicine, 10(13). : 2944-2944, 2021
김지원, 김현아, 서창희, 정주양
2021Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
Frontiers in medicine, 8. : 765535-765535, 2021
김지원, 김현아, 서창희, 정주양
2021Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review
Expert opinion on biological therapy, 21(1). : 57-73, 2021
김지원, 서창희, 정주양
2021Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease
Clinical rheumatology, 40(2). : 661-668, 2021
김지원, 김현아, 서창희, 정주양
2020COMPARISON OF INFLAMMATORY MARKERS AS DIAGNOSTIC TOOL IN PATIENTS WITH ADULT-ONSET STILL'S DISEASE
Annals of the rheumatic diseases, 79(S1). : 1220-1221, 2020
김지원, 김현아, 서창희, 정주양
2020DISEASE ACTIVITY IS IMPORTANT RISK FACTORS FOR MATERNAL AND FETAL OUTCOMES DURING PREGNANCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Annals of the rheumatic diseases, 79(S1). : 363-363, 2020
김지원, 김현아, 서창희, 정주양
2020SEASONAL VARIATIONS AND ASSOCIATED FACTORS OF GOUT ATTACKS: A PROSPECTIVE MULTICENTER STUDY IN SOUTH KOREA
Annals of the rheumatic diseases, 79(S1). : 458-459, 2020
김현아, 서창희, 정주양
2020A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis
Expert opinion on drug metabolism & toxicology, 16(12). : 1125-1132, 2020
서창희
2020Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
The Korean journal of internal medicine, 35(1). : 231-239, 2020
서창희
2020Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis
Journal of clinical medicine, 9(6). : 2008-2008, 2020
김지원, 서창희
2020Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease
Frontiers in immunology, 11. : 583513-583513, 2020
김지원, 김현아, 서창희, 정주양
2020A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models
Cells, 9(7). : 1648-1648, 2020
서창희
2020Trabecular Bone Score Is a Useful Parameter for the Prediction of Vertebral Fractures in Patients With Polymyalgia Rheumatica
Journal of clinical densitometry, 23(3). : 373-380, 2020
김현아, 서창희, 정윤석, 정주양, 최용준
2020A peptide derived from the core beta-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models
EBioMedicine, 52. : 102645-102645, 2020
서창희
2020A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
Clinical drug investigation, 40(6). : 541-553, 2020
서창희
2020Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies
Journal of Korean medical science, 35(38). : e335-e335, 2020
서창희
2020Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea
Journal of Korean medical science, 35(20). : e133-e133, 2020
김현아, 서창희, 정주양
2020Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis
Scandinavian journal of rheumatology, 49(5). : 361-370, 2020
서창희
2020The alphaC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases
Biomaterials, 245. : 119974-119974, 2020
김순선, 서창희, 정재연
2019Korean Guideline of Glucocorticoid-induced Osteoporosis; Time to Prevent Fracture!
Journal of rheumatic diseases, 26(2). : 87-89, 2019
서창희
2019Clinical Impact of the Fracture Risk Assessment Tool on the Treatment Decision for Osteoporosis in Patients with Knee Osteoarthritis: A Multicenter Comparative Study of the Fracture Risk Assessment Tool and World Health Organization Criteria
Journal of clinical medicine, 8(7). : 918-918, 2019
김현아, 서창희, 정주양
2019Associated clinical factors for serious infections in patients with systemic lupus erythematosus
Scientific reports, 9(1). : 9704-9704, 2019
김현아, 서창희, 윤덕용, 정주양, 최영
2019Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus
Scientific reports, 9(1). : 18565-18565, 2019
김현아, 서창희, 정주양
2019Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial
Rheumatology (Oxford, England), 58(12). : 2193-2202, 2019
서창희
2019Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis
International journal of molecular sciences, 20(20). : 5044-5044, 2019
김현아, 서창희, 손성향, 정주양
2019The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease
Clinical and experimental rheumatology, 37 Suppl 121(6). : 67-73, 2019
권지은, 김현아, 서창희, 임현이, 정주양, 한재호
2019Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study
Clinical and experimental rheumatology, 37(1). : 89-96, 2019
서창희
2019Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease
The Journal of rheumatology, 46(12). : 1560-1569, 2019
권지은, 김현아, 서창희, 정주양, 최용준, 한재호
2019Plasma Free Protein S Is Correlated with Disease Activity, but not with Subclinical Atherosclerosis among Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study
The Tohoku journal of experimental medicine, 249(1). : 1-7, 2019
김현아, 서창희, 정주양
2019NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO ARE ASSOCIATED WITH DISEASE ACTIVITY IN POLYMYALGIA RHEUMATICA
Annals of the rheumatic diseases, 78(Suppl.2). : 2123-2123, 2019
김지원, 김현아, 서창희, 정주양
2019PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER COMPARATIVE STUDY OF THE FRAX AND WHO CRITERIA
Annals of the rheumatic diseases, 78(Suppl.2). : 632-632, 2019
김지원, 김현아, 서창희, 정주양
2019CHARACTERIZATION OF SALIVARY PROTEINS IDENTIFIED AS POTENTIAL BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH PROTEOMIC ANALYSIS
Annals of the rheumatic diseases, 78(Suppl.2). : 2035-2036, 2019
김지원, 김현아, 서창희, 정주양
2019A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
Annals of the rheumatic diseases, 78(Suppl.2). : 1159-1160, 2019
서창희
2019The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease
Expert review of molecular diagnostics, 19(6). : 459-468, 2019
김현아, 서창희, 정주양
2019Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis
Expert opinion on biological therapy, 19(10). : 979-986, 2019
김지원, 김현아, 서창희, 정주양
2019Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus: A pilot study
Complementary therapies in clinical practice, 35. : 18-21, 2019
김현아, 서창희, 정주양, 조선미
2019Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica
Journal of clinical laboratory analysis, 33(9). : e23000-e23000, 2019
김현아, 서창희, 정주양
2019Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
Arthritis research & therapy, 21. : 122-122, 2019
서창희
2019Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study
International journal of rheumatic diseases, 22(8). : 1410-1418, 2019
김현아, 서창희, 정주양
2019Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians
PLoS genetics, 15(4). : e1008092-e1008092, 2019
서창희
2019The Liver X Receptor Is Upregulated in Monocyte-Derived Macrophages and Modulates Inflammatory Cytokines Based on LXRalpha Polymorphism
Mediators of inflammation, 2019. : 6217548-6217548, 2019
김현아, 서창희, 정주양
2019Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 33(1). : 79-91, 2019
서창희
2019Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study
Clinical rheumatology, 38(9). : 2483-2491, 2019
부선주, 서창희, 정주양
1 2 3 4 5 6 7

Browse